Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH.

scientific article published in October 2009

Chromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1309/AJCPXY3MJ6GSRCYP
P698PubMed publication ID19762528
P5875ResearchGate publication ID26820116

P50authorIan EllisQ55300055
P2093author name stringBharat Jasani
Anthony O'Grady
Silvana Di Palma
John M Morgan
Fiona M Campbell
Keith Miller
J M S Bartlett
Merdol Ibrahim
Yvonne Connolly
Elaine Kay
Jane Starczynski
Peter Wencyk
P4510describes a project that usesfluorescence in situ hybridizationQ1336182
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)514-520
P577publication date2009-10-01
P1433published inAmerican Journal of Clinical PathologyQ15750224
P1476titleChromogenic in situ hybridization: a multicenter study comparing silver in situ hybridization with FISH.
P478volume132

Reverse relations

cites work (P2860)
Q38612634Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens
Q55032245Application of the 2013 ASCO/CAP guideline and the SISH technique for HER2 testing of breast cancer selects more patients for anti-HER2 treatment.
Q44958097Bright-field microscopy for HER2 gene assessment: not just DISH-ful thinking?
Q26865068Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
Q46514019Comparison of fluorescence in situ hybridization (FISH) and dual-ISH (DISH) in the determination of HER2 status in breast cancer
Q38314355HER2 assessment by silver in situ hybridization: where are we now?
Q53158559HER2 status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhanced in situ hybridization (SISH).
Q35195417Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.
Q34064466Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma
Q27015506Quantification of HER family receptors in breast cancer
Q37932507The human epidermal growth factor receptor 2 (HER2).

Search more.